|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie J, Ying YY, Xu B, Li Y, Zhang X and Li
C: Metastasis pattern and prognosis of male breast cancer patients
in US: A population-based study from SEER database. Ther Adv Med
Oncol. 11:17588359198890032019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim MY: Breast cancer metastasis. Adv Exp
Med Biol. 1187:183–204. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Das V, Bhattacharya S, Chikkaputtaiah C,
Hazra S and Pal M: The basics of epithelial-mesenchymal transition
(EMT): A study from a structure, dynamics, and functional
perspective. J Cell Physiol. 234:14535–14555. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nieto MA: Epithelial-mesenchymal
transitions in development and disease: Old views and new
perspectives. Int J Dev Biol. 53:1541–1547. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johansen FE, Braathen R and Brandtzaeg P:
Role of J chain in secretory immunoglobulin formation. Scand J
Immunol. 52:240–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johansen FE, Braathen R and Brandtzaeg P:
The J chain is essential for polymeric Ig receptor-mediated
epithelial transport of IgA. J Immunol. 167:5185–5192. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bertrand FE III, Billips LG, Gartland GL,
Kubagawa H and Schroeder HW Jr: The J chain gene is transcribed
during B and T lymphopoiesis in humans. J Immunol. 156:4240–4244.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bjercke S and Brandtzaeg P: Glandular
distribution of immunoglobulins, J chain, secretory component, and
HLA-DR in the human endometrium throughout the menstrual cycle. Hum
Reprod. 8:1420–1425. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gui S, O'Neill WQ, Teknos TN and Pan Q:
Plasma cell marker, immunoglobulin J polypeptide, predicts early
disease-specific mortality in HPV+ HNSCC. J Immunother Cancer.
9:e0012592021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cruz-Rodriguez N, Combita AL, Enciso LJ,
Quijano SM, Pinzon PL, Lozano OC, Castillo JS, Li L, Bareño J,
Cardozo C, et al: High expression of ID family and IGJ genes
signature as predictor of low induction treatment response and
worst survival in adult Hispanic patients with B-acute
lymphoblastic leukemia. J Exp Clin Cancer Res. 35:642016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slizhikova DK, Zinov'eva MV, Kuz'min DV,
Snezhkov EB, Shakhparonov MI, Dmitriev RI, Antipova NV, Zavalova LL
and Sverdlov ED: Decrease in expression of human J-chain in lung
squamous cell cancer and adenocarcinoma. Mol Biol (Mosk).
41:659–665. 2007.In Russian. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang B, Li S, Jiang Z and Shao P: Gastric
cancer associated genes identified by an integrative analysis of
gene expression data. Biomed Res Int. 2017:72590972017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Larsson C, Ehinger A, Winslow S,
Leandersson K, Klintman M, Dahl L, Vallon-Christersson J, Häkkinen
J, Hegardt C, Manjer J, et al: Prognostic implications of the
expression levels of different immunoglobulin heavy chain-encoding
RNAs in early breast cancer. NPJ Breast Cancer. 6:282020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong Z, Jiang W, Zhang J, Li Z and Fan F:
Identification and validation of a novel 16-gene prognostic
signature for patients with breast cancer. Sci Rep. 12:123492022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Junjun S, Yangyanqiu W, Jing Z, Jie P,
Jian C, Yuefen P and Shuwen H: Prognostic model based on six PD-1
expression and immune infiltration-associated genes predicts
survival in breast cancer. Breast Cancer. 29:666–676. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Zhu M, Guo F, Song Y, Fan X and
Qin G: Identification of tumor microenvironment-related prognostic
biomarkers in luminal breast cancer. Front Genet. 11:5558652020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Győrffy B: Survival analysis across the
entire transcriptome identifies biomarkers with the highest
prognostic power in breast cancer. Comput Struct Biotechnol J.
19:4101–4109. 2021. View Article : Google Scholar
|
|
21
|
Wang M, Dai M, Wu YS, Yi Z, Li Y and Ren
G: Immunoglobulin superfamily member 10 is a novel prognostic
biomarker for breast cancer. PeerJ. 8:e101282020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Li Y, Huang J, Zeng B, Yang D, Sun J, Yin
X, Lu M, Qiu Z, Peng W, Xiang T, et al: PSMD2 regulates breast
cancer cell proliferation and cell cycle progression by modulating
p21 and p27 proteasomal degradation. Cancer Lett. 430:109–122.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kozłowski J, Kozłowska A and Kocki J:
Breast cancer metastasis-insight into selected molecular mechanisms
of the phenomenon. Postepy Hig Med Dosw (Online). 69:447–451. 2015.
View Article : Google Scholar
|
|
25
|
Stark AM, Tongers K, Maass N, Mehdorn HM
and Held-Feindt J: Reduced metastasis-suppressor gene
mRNA-expression in breast cancer brain metastases. J Cancer Res
Clin Oncol. 131:191–198. 2005. View Article : Google Scholar
|
|
26
|
Chakrabarti R, Hwang J, Blanco MA, Wei Y,
Lukačišin M, Romano RA, Smalley K, Liu S, Yang Q, Ibrahim T, et al:
Elf5 inhibits the epithelial-mesenchymal transition in mammary
gland development and breast cancer metastasis by transcriptionally
repressing Snail2. Nat Cell Biol. 14:1212–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li CJ, Chu PY, Yiang GT and Wu MY: The
molecular mechanism of epithelial-mesenchymal transition for breast
carcinogenesis. Biomolecules. 9:4762019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park M, Kim D, Ko S, Kim A, Mo K and Yoon
H: Breast cancer metastasis: Mechanisms and therapeutic
implications. Int J Mol Sci. 23:68062022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karamanou K, Franchi M, Vynios D and
Brézillon S: Epithelial-to-mesenchymal transition and invadopodia
markers in breast cancer: Lumican a key regulator. Semin Cancer
Biol. 62:125–133. 2020. View Article : Google Scholar
|
|
31
|
Wang H, Guo S, Kim SJ, Shao F, Ho JWK,
Wong KU, Miao Z, Hao D, Zhao M, Xu J, et al: Cisplatin prevents
breast cancer metastasis through blocking early EMT and retards
cancer growth together with paclitaxel. Theranostics. 11:2442–2459.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lüönd F, Sugiyama N, Bill R, Bornes L,
Hager C, Tang F, Santacroce N, Beisel C, Ivanek R, Bürglin T, et
al: Distinct contributions of partial and full EMT to breast cancer
malignancy. Dev Cell. 56:3203–3221.e11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chaffer CL, Juan BP, Lim E and Weinberg
RA: EMT, cell plasticity and metastasis. Cancer Metastasis Rev.
35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ho GY, Kyran EL, Bedo J, Wakefield MJ,
Ennis DP, Mirza HB, Vandenberg CJ, Lieschke E, Farrell A, Hadla A,
et al: Epithelial-to-mesenchymal transition supports ovarian
carcinosarcoma tumorigenesis and confers sensitivity to
microtubule-targeting with eribulin. Cancer Res. 83:4457–4473.
2022. View Article : Google Scholar
|
|
36
|
Hasmim M, Xiao M, Van Moer K, Kumar A,
Oniga A, Mittelbronn M, Duhem C, Chammout A, Berchem G, Thiery JP,
et al: SNAI1-dependent upregulation of CD73 increases extracellular
adenosine release to mediate immune suppression in TNBC. Front
Immunol. 13:9828212022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smith BN and Bhowmick NA: Role of EMT in
metastasis and therapy resistance. J Clin Med. 5:172016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang Y, Hong W and Wei X: The molecular
mechanisms and therapeutic strategies of EMT in tumor progression
and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chaffer CL, Marjanovic ND, Lee T, Bell G,
Kleer CG, Reinhardt F, D'Alessio AC, Young RA and Weinberg RA:
Poised chromatin at the ZEB1 promoter enables breast cancer cell
plasticity and enhances tumorigenicity. Cell. 154:61–74. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hashemi M, Moosavi MS, Abed HM, Dehghani
M, Aalipour M, Ali Heydari E, Behroozaghdam M, Entezari M,
Salimimoghadam S, Gunduz ES, et al: Long non-coding RNA (lncRNA)
H19 in human cancer: From proliferation and metastasis to therapy.
Pharmacol Res. 184:1064182022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar
|
|
42
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DS and Radisky ES: Tumor cell-produced matrix
metalloproteinase 9 (MMP-9) drives malignant progression and
metastasis of basal-like triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nagase H, Visse R and Murphy G: Structure
and function of matrix metalloproteinases and TIMPs. Cardiovasc
Res. 69:562–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jabłońska-Trypuć A, Matejczyk M and
Rosochacki S: Matrix metalloproteinases (MMPs), the main
extracellular matrix (ECM) enzymes in collagen degradation, as a
target for anticancer drugs. J Enzyme Inhib Med Chem. 31(sup1):
S177–S183. 2016. View Article : Google Scholar
|
|
45
|
Vallabhapurapu S and Karin M: Regulation
and function of NF-kappaB transcription factors in the immune
system. Annu Rev Immunol. 27:693–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Muaddi H, Majumder M, Peidis P, Papadakis
AI, Holcik M, Scheuner D, Kaufman RJ, Hatzoglou M and Koromilas AE:
Phosphorylation of eIF2α at serine 51 is an important determinant
of cell survival and adaptation to glucose deficiency. Mol Biol
Cell. 21:3220–3231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pal S, Bhattacharjee A, Ali A, Mandal NC,
Mandal SC and Pal M: Chronic inflammation and cancer: potential
chemoprevention through nuclear factor kappa B and p53 mutual
antagonism. J Inflamm (Lond). 11:232014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Julien S, Puig I, Caretti E, Bonaventure
J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A
and Larue L: Activation of NF-kappaB by Akt upregulates Snail
expression and induces epithelium mesenchyme transition. Oncogene.
26:7445–7456. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tsubaki M, Komai M, Fujimoto SI, Itoh T,
Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, et
al: Activation of NF-κB by the RANKL/RANK system up-regulates snail
and twist expressions and induces epithelial-to-mesenchymal
transition in mammary tumor cell lines. J Exp Clin Cancer Res.
32:622013. View Article : Google Scholar
|
|
50
|
Katoh M and Katoh M: Integrative genomic
analyses of ZEB2: Transcriptional regulation of ZEB2 based on
SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int J Oncol.
34:1737–1742. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL,
Chao CH, Yamaguchi H, Yang NK, Ding Q, et al:
Epithelial-mesenchymal transition induced by TNF-α requires
NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res.
72:1290–1300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang H, Wang HS, Zhou BH, Li CL, Zhang F,
Wang XF, Zhang G, Bu XZ, Cai SH and Du J: Epithelial-mesenchymal
transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated
stabilization of snail in colorectal cancer. PLoS One.
8:e566642013. View Article : Google Scholar
|
|
54
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar
|
